Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Plonk

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Acta Diabetologica Latina|January 1, 1976
Reliability of copper reduction methods for quantitation of glucosuriaJ W Plonk, J M Feldman
Journal of Clinical Pharmacology|February 1, 1976
Therapeutic doses of cyproheptadine do not inhibit monoamine oxidase in manJ M Feldman, J Roche, J W Plonk
The American Journal of the Medical Sciences|October 1, 1974
Alterations of pituitary-gonadal function in the carcinoid syndromeJ M Feldman, J W Plonk, C E Bivens
Clinical Endocrinology|January 1, 1976
Inhibitory effect of serotonin antagonists on growth hormone release in acromegalic patientsJ M Feldman, J W Plonk, C H Bivens
Life Sciences|September 15, 1974
Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretionJ M Feldman, B A Chapman, J W Plonk
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1975
The role of cortisol and growth hormone in the counter-regulation of insulin-induced hypoglycemiaJ M Feldman, J W Plonk, C H Bivens
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadineJ W Plonk, C H Bivens, J M Feldman
Prostaglandins|September 25, 1974
Serum prostaglandin F-2 alpha concentration in the carcinoid syndromeJ M Feldman, J W Plonk, J C Cornette
Cancer|November 1, 1976
Plasma amino acids in patients with the carcinoid syndromeJ M Feldman, J W Plonk, J Admiraal, et al.
Biochemical Medicine|June 1, 1977
Plasma para-chlorophenylalanine measurements with gas-liquid chromatography. Methodological and pharmacological studiesJ M Feldman, J Admiraal, J W Plonk, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Acta Diabetologica Latina|January 1, 1976
Reliability of copper reduction methods for quantitation of glucosuriaJ W Plonk, J M Feldman
Journal of Clinical Pharmacology|February 1, 1976
Therapeutic doses of cyproheptadine do not inhibit monoamine oxidase in manJ M Feldman, J Roche, J W Plonk
The American Journal of the Medical Sciences|October 1, 1974
Alterations of pituitary-gonadal function in the carcinoid syndromeJ M Feldman, J W Plonk, C E Bivens
Clinical Endocrinology|January 1, 1976
Inhibitory effect of serotonin antagonists on growth hormone release in acromegalic patientsJ M Feldman, J W Plonk, C H Bivens
Life Sciences|September 15, 1974
Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretionJ M Feldman, B A Chapman, J W Plonk
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1975
The role of cortisol and growth hormone in the counter-regulation of insulin-induced hypoglycemiaJ M Feldman, J W Plonk, C H Bivens
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadineJ W Plonk, C H Bivens, J M Feldman
Prostaglandins|September 25, 1974
Serum prostaglandin F-2 alpha concentration in the carcinoid syndromeJ M Feldman, J W Plonk, J C Cornette
Cancer|November 1, 1976
Plasma amino acids in patients with the carcinoid syndromeJ M Feldman, J W Plonk, J Admiraal, et al.
Biochemical Medicine|June 1, 1977
Plasma para-chlorophenylalanine measurements with gas-liquid chromatography. Methodological and pharmacological studiesJ M Feldman, J Admiraal, J W Plonk, et al.
Pageof 3